CED-7 You Did What to Whom, They Want How Much?

3.5 (4 votes)

CE Hours: 1.5

Description: Dr. John Olmsted will present case studies of several real endodontic malpractice cases to the audience. He will highlight endodontic procedures that became issues for dentists, and also endodontic procedures that developed problems for endodontists. A discussion will follow each case, giving the audience a chance to discuss the risk management issues involved in each case. The audience will then be asked to act as a jury, reaching a verdict on the case, and a dollar amount on a judgment. The audience will then be given the real-life verdicts and awards.

Learning Objectives: 

  • Explain how errors in record keeping, diagnosis, treatment planning, and endodontic treatment will affect the claims handling and legal process
  • List the cost in terms of judgments rendered against dentists/endodontists through the discussion of real-life malpractice case examples
  • Outline the steps of risk management


Open to view video.
8 Questions
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
1.50 CE credits  |  Certificate available
1.50 CE credits  |  Certificate available

John S. Olmsted, D.D.S., M.S.

Dr. John Olmsted, 35 years clinical endo in a large group practice, is a past AAE President, past General Chairperson ADA 2004 Orlando Meeting. John earned his DDS, OKU from Iowa in 1975, his MS from the UNC-Chapel Hill in 1977, and he is currently a Clinical Professor in Endodontics at the UNC and Iowa. He is ABE certified and FAGD, FICD, FPFA, & FACD. John has presented 650 days of lectures, workshops, and seminars, at dental schools, state, regional, national, international meetings. He has served 25 years on the Board of Directors for Medical Mutual Insurance Company and 9 years on the Board of Directors for EDIC.

Speaker Disclosure 

I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.